Eligible individuals may claim compensation for purchases made since 2016.
- Consumers can receive payments for qualifying blood pressure medications.
- Eligibility includes purchases made from January 1, 2016, to the present.
- Affected medications include valsartan, irbesartan, and losartan.
Individuals who purchased certain blood pressure medications, specifically hetero valsartan, Aurobindo irbesartan, or Vivimed losartan, between January 1, 2016, and now, may be eligible for compensation. This compensation is part of a settlement for various retail purchases of these medications. Affected consumers are encouraged to check their eligibility for potential payments.
To be eligible, purchasers must have bought the specified medications during the defined timeframe. The settlement aims to address issues related to these drugs and provide reimbursement for consumers who were impacted. Further details can help individuals ensure they meet the criteria for claiming payment.
This initiative highlights the ongoing concerns regarding the safety and regulation of prescription medications and their potential side effects. Consumers should stay informed about how these settlements can assist them in receiving compensation related to their purchases of blood pressure medications.
